Technology | Magnetic Resonance Imaging (MRI) | February 17, 2017

FDA Clears Siemens Magnetom Sempra MRI System

Cost-efficient system includes standardized, automated workflows for nearly 75 percent of MRI exams

Siemens Healthineers, Magnetom Sempra MRI system, FDA approval, RSNA 2017

February 17, 2017 — Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sempra 60-cm 1.5 Tesla (1.5T) magnetic resonance imaging (MRI) system.

Siemens said the Magnetom Sempra is distinguished by its low operating costs, innovative technologies, and full-coverage service contract, which help radiological practices and groups, as well as small- and medium-sized hospitals, operate profitably despite rising industry cost pressures. Additionally, the system’s standardized workflows are designed to help facilities achieve consistent, user- and patient-independent levels of quality.

With Day optimizing throughput (Dot) workflow engines, the system enables the user to adjust to each clinical case and to the condition of each patient while simultaneously maintaining exam standardization. The system comes equipped with three Dot engines to automate and streamline workflow for brain, spine and large joint procedures. These Dot engines cover roughly three-quarters of the average exam volume and help users increase productivity in addition to avoiding unnecessary and costly repeat scans.

The Magnetom Sempra includes applications that enable facilities to respond to competitive pressure and adapt to changing market demands. For example, facilities can scan in the presence of MRI-safe metallic implants with improved visualization of surrounding soft tissue, including hip and knee implants. The system’s software platform includes the company’s etablished Quiet Suite technology, which can reduce sound pressure by up to 97 percent in brain and musculoskeletal exams while delivering high-quality images. Quiet Suite technology can benefit anxious patients and offer a more positive exam experience.

With its equipped Dot engines, the Magnetom Sempra enables users to perform exams in just 10 minutes – including a brain exam, from patient positioning to exam completion – using time- and image-optimized protocols that cover most commonly scanned body parts.

To reduce overall operating costs, the system offers Eco-Power technology, which monitors and controls the magnet-cooling helium to reduce energy consumption by up to 30 percent compared to the system’s normal mode. Zero Helium boil-off technology, a supplementary feature, prevents helium evaporation, so operators can avoid expensive helium refills and resultant downtimes.

For more information: www.usa.siemens.com

Related Content

This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...